Articles

Merrill Lynch and Harvest Volatility paying $9.3 million in fines for derivatives trades

Fines follow probe of Harvest’s Collateral Yield Enhancement Strategy (CYES).

No trust is set in stone. Even irrevocable trusts can have some wiggle room.

Media titan Rupert Murdoch is in court to test the boundaries of changing permanent estate plans.

Flutter Entertainment’s stock up 8% after FanDuel parent outlines growth plans and unveils $5 billion share buyback

FanDuel boosted its outlook for the size of the total addressable market in North America.

AT&T’s stock is trading near three-year highs. Here’s what’s clicking.

While rate-cut optimism could be helping AT&T’s stock toward its best month in nearly two years, there’s also been growing validation of the company’s fiber strategy.

The 10-year Treasury yield is climbing after the Fed’s big rate cut. Why investors should be concerned.

The Federal Reserve is all about delivering a soft landing for the economy. Investors aren’t totally convinced.

Target Hospitality’s stock tumbles 24% after buyout committee disbanded

Target Hospitality Corp.’s stock tumbled 24% early Wednesday, after the provider of modular housing said it has disbanded a special committee created to review a buyout offer after the bidder failed to follow through on its offer.

Why this holiday season, shoppers might finally be ready to buy fancier stuff

From Nov. 1, when holiday spending picks up in earnest, through Dec. 31, Adobe expects U.S. online sales of $240.8 billion, an 8.4% gain and a new record.

Reddit extends machine-learning translation to 35 new countries, including Brazil and Spain

Social-media platform Reddit is rolling out machine-learning translation to a slew of new countries.

My wife and I immigrated to the U.S. with our son, 25. We have $45,000. Do we buy a house in California — or save our money?

“We are all naturalized citizens. We have a small savings of over $45,000 deposited in a high-yield savings account.”

Buy Tesla’s stock ahead of these ‘significant’ positive catalysts, analyst says

Tesla’s stock has been on a tear in September, and Baird analyst Ben Kallo expects more gains are to come after the electric vehicle giant reports deliveries data next week.

Merck says trial of combination treatment for colon cancer failed to meet main goal

Merck & Co.’s said a late-stage trial of its blockbuster cancer drug Keytruda in combination with favezelimab failed to meet the main goal of overall survival (OS) as a treatment for a type of colon cancer.

China stimulus plans spark a commodities rally, but a soft landing still isn’t a sure bet

Commodity prices have climbed this week, with oil, silver, and copper among the more recent standouts, buoyed by China’s stimulus measures, but traders should be wary about the outlook for the sector until they see evidence that the global economy will avoid a hard landing.
1 804 805 806 807 808 2,370